Author

Hui Wang

University of PittsburghORCID 0009-0006-1418-4658Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Hui Wang12 papers · The University of Texas Medical Branch at Galveston

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Adam G. ChatoffiD· 1 shared Aidan R. ColeiD· 1 shared Amandine AmalriciD· 1 shared Apoorva UbovejaiD· 1 shared Baixue YangiD· 1 shared Claudia V. CrispimiD· 1 shared Costas Andreas LyssiotisiD· 1 shared Jiefei WangiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam G. ChatoffORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer Research CommunicationsPeer-reviewedApr 16, 2024

De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression

Naveen Kumar Tangudu, Raquel Buj, Hui Wang…·Katherine M. Aird

This study identifies de novo purine metabolism as a vulnerability in cancers with low p16 expression, showing sensitivity to anti-folate drugs like methotrexate.

14 citations

𝕏 PostBluesky